When I read an article like the one below I think two things:
1) First, I wonder why the article’s author, Désirée Lie, MD, MSEd, thinks that she has the right to “guide” minority women urging them to undergo mammography.
There are too many studies indicating that BC is over-diagnosed and over-treated-
“Mammorgrams save lives…” “Mammograms lead to over-diagnosis and over-treatment.” Back and forth… Both sides present reasonable arguements. Both sides can be convincing.
What’s a newly diagnosed BC patient to do???
The first thing to do if for all of us to agree on the point made below that
“Bc without risk for metastases does not need to be treated with postoperative chemotherapy. Such treatment offers no benefit to these women, he added.”
2) Second, I wonder why conventional oncology doesn’t research and prescribe non-toxic, inexpensive therapies to dramatically reduce breast cancer risk. My point is that if more women pursued the non-toxic, inexpensive therapies linked below there would be perhaps there would be fewer disparities.
To learn more about both integrative and non-conventional BC therapies scroll down the page, post a question or comment and I will reply to you ASAP.
Articles of Interest-
“In my blog post “Slash Your Breast Cancer Risk Now!” I document studies that show supplementation, vitamins, exercise, nutrition/diet and more that dramatically reduces the risk of a breast cancer diagnosis. The anti-BC therapies listed below reduce the risk of BC by 80%-conservatively….”
Summary: “There are many underlying reasons for racial and ethnic disparities that affect BC mortality, eg, inadequate screening of some minority groups. Mammography screening improves mortality outcomes. Clinicians should be cognizant of the disparate survival outcomes in their vulnerable populations when interpreting the recent 2009 USPSTF breast cancer screening guidelines, especially in light of evidence from the Kaiser Family Foundation report on disparities in women’s health that confirmed the persistence of disparities in screening, diagnosis, and treatment of the most common health conditions across all US states.[32,33] Routine biennial mammography screening in the 40-year to 49-year age group should be recommended in these vulnerable women.”